Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome for postoperative analgesia in elderly hip fracture surgery
ChiCTR2500102867Phase 4Recruiting
- Sponsor
- Beijing Jishuitan Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in hip fracture (2 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoint: VAS score. Started May 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2500102867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102867.